Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The 35-mm slide--is blue better?

G R Heudebert, J Van Ruiswyk, J C Byrd

    Journal of General Internal Medicine
    |May 1, 1990
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    The changing practice of transurethral resection of the prostate.

    Annals of the Royal College of Surgeons of England·2018
    Same author

    Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    SMV1, an extremely stable thermophilic virus platform for nanoparticle trafficking in the mammalian GI tract.

    Journal of applied microbiology·2017
    Same author

    Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.

    Leukemia·2017
    Same author

    PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment.

    Leukemia·2017